Investor positioning shifts as European banks and tech take the lead

Fidelity European Trust

European markets began the week with modest but telling strength. While the overall move was measured, the underlying shifts in sector leadership point to a change in how capital is being allocated. Tech and banking stocks led gains across the Stoxx Europe 600, with technology rising over 1 % and financials not far behind. These are not speculative rotations.

Driving sentiment is a recalibration of macro risk. Softer US inflation data has strengthened the case for the Federal Reserve to begin easing, with a potential rate cut back on the table as early as March. That has filtered across to European markets, particularly as it coincides with better-than-expected corporate results. Notably, German business sentiment indicators ticked higher, reinforcing confidence that economic activity across the eurozone may be stabilising after months of strain.

Banks are benefiting from improved net interest margin expectations, while technology stocks are attracting capital on the back of durable demand for hardware and AI-linked infrastructure. Export-heavy names are also starting to see valuation support, helped by a more constructive view on global trade following an easing in US–China tensions. At the same time, defensives like healthcare and insurance continue to see steady inflows.

Fidelity European Trust PLC (LON:FEV) aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Fidelity European Trust rose in October with chipmaker ASML top contributor

Fidelity European Trust reported several positives in October, with strong contributions from ASML and Assa Abloy following solid Q3 updates and resilient demand in key areas.

Are European equities set for a revival?

Marcel Stötzel, Co-Portfolio Manager of Fidelity European Trust, remains positive on Europe’s investment outlook, citing structural reforms, rising defence spending and potential economic integration as key drivers.

Fidelity European Trust continued rise as shares advanced in ASML and AIB

Fidelity European Trust has published its September 2025 factsheet, noting European equities finished the quarter higher despite mixed sector performance.

Investing in Europe: Why investors should remain positive

Co-Portfolio Manager of the Fidelity European Trust PLC (LON:FEV), outlines why he believes quality businesses backed by strong balance sheets and dividend growth potential remain well placed to deliver strong relative returns over the long-term.

Fidelity European Trust rises in August, reporting 16.4% returns in 2025

Fidelity European Trust highlighted strong contributions in August 2025 from KBC Groupe, which upgraded full year guidance, and Novo Nordisk, which advanced on positive trial results and regulatory approval for Wegovy.

Fidelity European Trust Factsheet – July volatility, Legrand and Bankinter gains

Continental European equities were volatile in July, with the Trust underperforming the index due to weak stock selection in financials and healthcare. Novo Nordisk and ASML detracted, while Legrand and Bankinter contributed positively. Over 12 months, the Trust’s NAV rose 1.8% and the share price 1.7%, compared with an 11.3% gain for the index.

Search

Search